Literature DB >> 19924504

The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features.

Alessandra Nicoletti1, Pierfrancesco Pugliese, Giuseppe Nicoletti, Gennarina Arabia, Grazia Annesi, Michele De Mari, Paolo Lamberti, Simone Gallerini, Roberto Marconi, Antonio Epifanio, Letterio Morgante, Autilia Cozzolino, Paolo Barone, Giuseppina Torchia, Aldo Quattrone, Mario Zappia.   

Abstract

The Fattori di Rischio Ambientali e Genetici Associati alla Malattia di Parkinson (FRAGAMP) study is a multicenter case-control study carried out to evaluate the possible role of environmental and genetic factors in Parkinson's disease (PD). Cases and controls were enrolled from five Movement Disorder centers in Central-Southern Italy. PD was diagnosed according to Gelb's criteria while the control groups consisted of the spouses of the enrolled patients or of healthy controls matched by age and area of residence. Cases and controls underwent a standardised questionnaire and a blood sample was taken for molecular analyses. At the end of the study 585 cases and 481 control subjects (287 spouse-controls and 194 generic-controls) were enrolled. Patients had a Hoehn-Yahr score of 2.3 +/- 0.8; 85% of them took levodopa and 47% had motor complications. The FRAGAMP study represents one of the largest case-control studies carried out in Europe to investigate the possible role of environmental and genetic factors in PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924504     DOI: 10.1007/s10072-009-0182-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

Review 1.  Association study designs for complex diseases.

Authors:  L R Cardon; J I Bell
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Variability and validity of polymorphism association studies in Parkinson's disease.

Authors:  E K Tan; M Khajavi; J I Thornby; S Nagamitsu; J Jankovic; T Ashizawa
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

4.  Studying risk factors for Parkinson's disease.

Authors:  Marjolijn Bornebroek; Monique Breteler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

6.  Education and occupations preceding Parkinson disease: a population-based case-control study.

Authors:  R Frigerio; A Elbaz; K R Sanft; B J Peterson; J H Bower; J E Ahlskog; B R Grossardt; M de Andrade; D M Maraganore; W A Rocca
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Pesticides and risk of Parkinson disease: a population-based case-control study.

Authors:  Jordan A Firestone; Terri Smith-Weller; Gary Franklin; Phillip Swanson; W T Longstreth; Harvey Checkoway
Journal:  Arch Neurol       Date:  2005-01

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  4 in total

1.  Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Alessandra Nicoletti; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  J Neurol       Date:  2016-03-10       Impact factor: 4.849

2.  Head trauma and Parkinson's disease: results from an Italian case-control study.

Authors:  Alessandra Nicoletti; Rosario Vasta; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  Neurol Sci       Date:  2017-07-26       Impact factor: 3.307

Review 3.  Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis.

Authors:  Charles B Breckenridge; Colin Berry; Ellen T Chang; Robert L Sielken; Jack S Mandel
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

4.  Exome-wide association study of levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Andrew A Hicks; Mario Zappia; Peter P Pramstaller; Eva König; Alessandra Nicoletti; Cristian Pattaro; Grazia Annesi; Roberto Melotti; Alessandro Gialluisi; Christine Schwienbacher; Anne Picard; Hagen Blankenburg; Irene Pichler; Nicola Modugno; Marina Ciullo; Teresa Esposito; Francisco S Domingues
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.